Govt to sell entire stake in IMPCL, invites bids for asset valuer

Bidders would be required to submit their interest by January 15 to the ministry.

Image
Press Trust of India New Delhi
Last Updated : Dec 26 2017 | 8:47 PM IST
The government will sell its entire stake in Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) and is looking for a firm to value the assets of the company.

IMPCL is engaged in manufacture and supply of 'ayurvedic' and 'unani' medicines and is under the administrative control of Ministry of AYUSH with 98.11 per cent stake held by Government of India and the remaining 1.89 per cent by an Uttarakhand government PSU.

"The Government of India is considering strategic disinvestment of 100 per cent of its equity in IMPCL via a two-stage auction process. Ministry of AYUSH requires the services of a reputed Asset Valuer to carry out the valuation," the government said while inviting request for the proposal.

Bidders would be required to submit their interest by January 15 to the ministry.

The broad scope of work for the asset valuer is to carry out valuation of land and buildings, furniture and fixtures, lab and manufacturing equipment.

The property would be valued by any one or a combination of Comparison Method, Income Capitalisation, Discounted Cash Flow, Cost Approach method and Replacement valuation.

IMPCL is an unlisted company and as on November 1, 2017, the company has 120 employees.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 26 2017 | 8:47 PM IST

Next Story